%0 Journal Article
%T Stereotactic body radiotherapy: current strategies and future development
%A Tsang, Maverick W. K.
%J Journal of Thoracic Disease
%D 2016
%B 2016
%9 
%! Stereotactic body radiotherapy: current strategies and future development
%K 
%X Stereotactic body radiotherapy (SBRT) has emerged as the standard treatment for medically inoperable early-staged non-small cell lung cancer (NSCLC). The local control rate after SBRT is over 90%. Some forms of tumour motion management and image-guided radiation delivery techniques are the prerequisites for fulfilment of its goal to deliver a high radiation dose to the tumour target without overdosing surrounding normal tissues. In this review, the current strategies of tumour motion management will be discussed, followed by an overview of various image-guided radiotherapy (RT) systems and devices available for clinical practice. Besides medically inoperable stage I NSCLC, SBRT has also been widely adopted for treatment of oligometastasis involving the lungs. Its possible applications in various other cancer illnesses are under extensive exploration. The progress of SBRT is critically technology-dependent. With advancement of technology, the ideal of personalised, effective and yet safe SBRT is already on the horizon.
%U https://jtd.amegroups.org/article/view/6933
%P S517-S527
%@ 2077-6624